Retinoic acid-induced differentiation of the human promyelocytic leukemia cell line, HL-60, and fresh human leukemia cells in primary culture: a model for differentiation inducing therapy of leukemia.
D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects*; D002460:Cell Line; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D006801:Humans; D007938:Leukemia / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D008222:Lymphokines / Q000378:metabolism; D009000:Monocytes / Q000166:cytology / Q000187:drug effects; D009857:Oncogenes; D044042:Receptors, Formyl Peptide; D011971:Receptors, Immunologic / Q000502:physiology; D013601:T-Lymphocytes / Q000378:metabolism; D014212:Tretinoin / Q000494:pharmacology* / Q000627:therapeutic use
D001095:Arachidonic Acids; D008222:Lymphokines; D044042:Receptors, Formyl Peptide; D011971:Receptors, Immunologic; C050979:monocyte-macrophage differentiation factor; D016718:Arachidonic Acid; D014212:Tretinoin; D000242:Cyclic AMP